PPC

Pilgrim's Pride Corporation - 10-Q Summary

Business Context and Reporting Period

This filing covers the quarterly period ended December 28, 2002 (Fiscal Q1 2003). Pilgrim's Pride Corporation operates in two primary segments: Chicken and Other Products (U.S. and Mexico) and Turkey Products. The quarter was significantly impacted by a voluntary product recall due to Listeria contamination at a Pennsylvania facility and the continuing effects of an avian influenza outbreak in Virginia.

Key Financial Metrics

Margins: Gross profit margin decreased to 6.8% from 8.8% year-over-year. Operating margin declined to 1.6% from 3.6%.

Material Changes vs. Prior Period

• Revenue Decline: Net sales decreased 4.4% ($28.6 million). U.S. chicken sales dropped $15.7 million due to lower pricing caused by export restrictions to Russia and Japan. Turkey sales fell $22.0 million due to the Listeria recall and avian influenza impacts.
• Profitability Drop: Operating income fell 56% ($13.0 million) and Net Income fell 79% ($10.2 million). This was driven by lower selling prices, higher feed costs, and the recall, partially offset by non-recurring recoveries.
• Non-Recurring Recoveries: The company recorded $14.4 million in recoveries, primarily $14.3 million in federal compensation for the avian influenza outbreak and $0.1 million from antitrust litigation.
• Recall Impact: The Listeria recall at the Franconia, PA plant negatively affected sales by approximately $30.0 million and operating margins by $5.0 million to $10.0 million during the quarter.

Outlook, Risks, and Contingencies

• Avian Influenza: Production in the turkey operation is expected to remain significantly reduced for the next three months. Management anticipates operating income from the turkey operation will decrease by $4.0 million to $7.0 million in Q2 2003 compared to the prior year.
• Recall Insurance: The company has recorded $14.7 million in recall-related expenses (net of deductible and advance payment) as receivables, believing them covered by insurance. However, the company has not secured a product recall insurance policy for calendar 2003 due to an unsettled insurance market.
• Legal Proceedings:
  • Antitrust: Received $22.5 million in partial settlements for vitamin price-fixing claims (to be reported in Q2) and $6.5 million for methionine price-fixing claims (to be reported in Q2).
  • Class Actions: Facing a class action lawsuit regarding the Listeria recall and a separate class action from chicken growers alleging violations of the Packers and Stockyards Act.
• Liquidity: The company maintains $130.0 million in revolving credit facilities and $400.0 million in a secured revolving/term facility. Approximately $330.1 million remains available under these facilities.

Investor Verification Checklist

• Insurance Coverage: Verify the status of the $14.7 million receivable related to the Listeria recall and the likelihood of full recovery given the insurer's reservation of rights.
• Recall Insurance Renewal: Confirm if the company has successfully obtained product recall insurance for 2003, as the lack thereof poses a significant risk.
• Avian Flu Compensation: Monitor the distribution of the remaining federal compensation for the avian influenza outbreak (approx. 28.4% of the $51.0 million estimate remains undistributed).
• Export Restrictions: Assess the duration and impact of import bans by Russia, Japan, and Mexico on U.S. poultry sales and pricing.
• Antitrust Settlements: Track the timing and accounting treatment of the $29.0 million in pending antitrust settlements to be recognized in Q2 2003.